Erik Schadde to Embolization, Therapeutic
This is a "connection" page, showing publications Erik Schadde has written about Embolization, Therapeutic.
Connection Strength
2.357
-
Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patients. HPB (Oxford). 2022 03; 24(3):413-421.
Score: 0.745
-
Simultaneous portal and hepatic vein embolization before major liver resection. Langenbecks Arch Surg. 2021 Aug; 406(5):1295-1305.
Score: 0.696
-
Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy. Ann Surg Oncol. 2015 Sep; 22(9):3109-20.
Score: 0.468
-
Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies. Curr Oncol Rep. 2020 05 16; 22(6):59.
Score: 0.171
-
ALPPS as a salvage procedure after insufficient future liver remnant hypertrophy following portal vein occlusion. HPB (Oxford). 2017 12; 19(12):1126-1129.
Score: 0.142
-
Hepatic parenchymal transection increases liver volume but not function after portal vein embolization in rabbits. Surgery. 2017 10; 162(4):732-741.
Score: 0.136